

Trillion Dollar Shot, Episode 4: The Disruptors
The rising popularity of GLP-1 drugs could cause all kinds of ripple effects. According to one estimate, 9% of the U.S. population could be on Ozempic or similar medications by 2030. Meanwhile, drugmakers are already developing the next generation of weight-loss drugs and researchers are studying the possible health…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like The Journal. →
Here's How the New Weight Loss Drugs Could Change Everything

Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

The State of Weight-Loss Drugs

Why People Are Losing Faith in Healthcare
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.
